E2AD: Enhanced and explainable Alzheimer's disease detection framework via anatomy- and relation-aware cross-modal

Chenhui Wang1, Sirong Piao2, Zhihao Chen1

  • 1Institute of Science and Technology for Brain-inspired Intelligence, Fudan University, Shanghai 200433, China.

Insights

This study introduces E²AD, an enhanced and explainable framework for Alzheimer's disease (AD) detection using MRI-only data. It improves diagnostic accuracy and generalizability by leveraging cross-modal knowledge distillation.

Area of Science:

  • Neuroimaging
  • Artificial Intelligence
  • Medical Diagnostics

Background:

  • Alzheimer's disease (AD) diagnosis relies on MRI and PET, but PET is costly and unavailable.
  • Existing MRI-only methods underutilize multimodal information, limiting robustness and generalizability.
  • There is a need for advanced MRI-only diagnostic systems that benefit from multimodal supervision.

Purpose of the Study:

  • To introduce E²AD, an Enhanced and Explainable AD detection framework.
  • To leverage anatomy- and relation-aware cross-modal knowledge distillation (KD) for improved MRI-only AD diagnosis.
  • To enhance clinical utility through explainable AI and structured MRI reporting.

Main Methods:

  • Developed E²AD framework using paired MRI-PET data for training and MRI-only for inference.
  • Implemented anatomy-aware distillation via an anatomical Mixture-of-Mappers for spatial cue transfer.
  • Incorporated relation-aware distillation for stable between-subject structural relation alignment.
  • Introduced a multi-agent workflow for translating attention maps into clinician-oriented MRI reports.

Main Results:

  • E²AD demonstrated superior performance over state-of-the-art baselines on ADNI, AIBL, and NACC cohorts.
  • Achieved faster convergence, improved data efficiency, and stronger cross-cohort generalization.
  • Showcased enhanced explainability with clinically traceable anatomical cues.

Conclusions:

  • E²AD offers a robust and explainable MRI-only approach for Alzheimer's disease detection.
  • The framework effectively utilizes cross-modal knowledge distillation for enhanced diagnostic performance.
  • E²AD has the potential to improve clinical workflows and accessibility of AD diagnostics.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
38
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
44
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35